The Colorectal Translational Research Group (CTRG) formalises a successful collaboration that incorporates research expertise from a broad range of disciplines including surgery, medical oncology, molecular biology, bioinformatics, immunology, and experimental pathology.
The CTRG is a collaboration of researchers from the Departments of Surgical Sciences, Medicine, Pathology, and Preventive and Social Medicine (the Hugh Adam Cancer Epidemiology Unit) at the Dunedin School of Medicine, and the Cancer Genetics Laboratory and Department of Microbiology and Immunology at the Otago School of Medical Sciences.
Colorectal cancer is a major cause of cancer-related mortality in New Zealand. Collaboration enables CTRG researchers to share resources to undertake research with the ultimate aim of improving cancer outcomes.
- To maximise research opportunities into colorectal cancer
- To provide a strong clinical base for laboratory-based research by recruiting patients into studies and procuring tissue samples linked to clinical outcome data
- To promote the translation of laboratory discoveries into the clinical environment
Main research areas
- Genetic and epigenetic factors in colorectal cancer
- Prognostic tests for colorectal cancer
- Immune response to colorectal cancer
- Immunotherapy for colorectal cancer
- Immune mechanisms in Crohn's disease
- Clinical trials
The CTRG's work contributes to the broader goals of the University of Otago's Centre for Translational Cancer Research, and promotes synergies with other research groups in New Zealand.
The CTRG team.